MBRX - Moleculin Biotech - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MBRX is currently covered by 1 analysts with an average price target of $22. This is a potential upside of $-15.21 (2550.6%) from yesterday's end of day stock price of $0.83.

Moleculin Biotech's activity chart (see below) currently has 9 price targets and 14 ratings on display. The stock rating distribution of MBRX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 79.17% with an average time for these price targets to be met of 226 days.

Highest price target for MBRX is $22, Lowest price target is $22, average price target is $22.

Most recent stock forecast was given by from HC WAINWRIGHT on 24-Mar-2026. First documented stock forecast 17-Oct-2019.

Currently out of the existing stock ratings of MBRX, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Sep-2025

$22

$18.73 (572.78%)

$4

5 months 18 days ago
(24-Mar-2026)

1/2 (50%)

$19.75 (877.78%)

99

Buy Since 09-Jun-2025

$4

$0.73 (22.32%)

$4

1 years 2 months 24 days ago
(18-Jun-2025)

2/2 (100%)

$-10.58 (-72.57%)

188

Buy Since 14-Dec-2023

$8

1 years 5 months 17 days ago
(25-Mar-2025)

3/3 (100%)

$-18.5 (-69.81%)

190

Hold Since 25-Mar-2025

$4

$0.73 (22.32%)

1 years 5 months 17 days ago
(25-Mar-2025)

1/1 (100%)

$-24.75 (-86.09%)

268

Buy Since 14-Apr-2021

$30

$26.73 (817.43%)

2 years 28 days ago
(14-Aug-2024)

3/3 (100%)

$-32.5 (-52.00%)

380

Show more analysts

Please expand the browser size to see the chart

What is MBRX (Moleculin Biotech) average time for price targets to be met?

On average it took 226 days for the stock forecasts to be reached, with an average price target met ratio of 79.17%.

Which analyst most recently updated their price target on MBRX (Moleculin Biotech)?

Which analyst has the most public recommendations on MBRX (Moleculin Biotech)?

has 0 price targets and 0 ratings on MBRX

Which analyst is the currently most bullish on MBRX (Moleculin Biotech)?

Jonathan Aschoff with the highest potential upside of $27.88

Which analyst is the currently most reserved on MBRX (Moleculin Biotech)?

Vernon Bernardino with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?